Please wait while we load the requested 10-KT report or click the link below:
https://last10k.com/sec-filings/report/1527728/000121390015007370/f10kt2015_dandritbio.htm
March 2018
February 2018
January 2018
January 2018
November 2017
October 2017
Please wait while we load the requested 10-KT report or click the link below:
https://last10k.com/sec-filings/report/1527728/000121390015007370/f10kt2015_dandritbio.htm
Compare this to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Dandrit Biotech Usa, Inc..
Dandrit Biotech Usa, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2015 10-K Annual Report includes:
Financial Statements, Disclosures and Schedules
Inside this
Ticker: DDRT
CIK: 1527728
Form Type:
Accession Number: 0001213900-15-007370
Submitted to the SEC: Tue Sep 29 2015 11:13:07 PM EST
Accepted by the SEC: Mon Sep 28 2015
Period: Tuesday, June 30, 2015
Industry: Pharmaceutical Preparations